Menu
Home
About Us
Who We Are
Our Purpose and Values
Board
Partners
Distributors
Compliance
Careers
Technology
Our Solution
Technology Introduction
Platform Technology
Publications
Image Gallery
Webinars
FAQ
Products
Our Products
InVivage
ViewnVivo
Customisation
Pipeline
Investor
Investor Overview
ASX Announcements
Reports
Share Price Information
Financial Calendar
Media Coverage
Sustainability
Share Registry
Investor Alerts
Media
News
Social Media Feed
Blog / Newsletter
Contact
Contact
Select Category
Clinical Research
Oral cancer diagnosis and surgical margin
Brain cancer
General surgery
Cervical assessment
Gastrointestinal assessment
Life Sciences Research
Cell viability
Live antibody labelling
Intraoperative surgery and tumour margin delineation
Blood vessel, perfusion, and barrier function
Live microflora imaging
Nano particle and drug delivery
Proof of concept in live models
Recent Posts
Optiscan Imaging Featured in Australian Financial Review
Dr. Camile Farah talks with Matt Birney on 2GB Sydney Radio
Optiscan Launches World Cancer Day 2023 Awareness Initiative
Dr. Camile Farah talks with Matt Birney on 6PR Perth Radio
Dr. Camile Farah talks with Matt Birney on 3AW 693 Melbourne Radio
Archives
March 2023
February 2023
January 2023
November 2022
September 2022
February 2022
May 2021
March 2021
January 2021
December 2020
Categories
Announcements
Blood vessel, perfusion, and barrier function
Brain cancer
Broker Research
Cell viability
Cervical assessment
Gastrointestinal assessment
General surgery
Intraoperative surgery and tumour margin delineation
Live antibody labelling
Live microflora imaging
Nano particle and drug delivery
Optiscan news
Oral cancer diagnosis and surgical margin
Proof of concept in live models
Uncategorized
Optiscan Imaging and Prolucid Featured in The Market Herald
January 31st, 2023 by Andrew Barker
Read More
1
Back to All Publications
